← SynDRA
METHOCARBAMOL
SynDRA canonical compound SYN0023408 — structure-anchored drug synonym record
| Clinical phase | Launched |
| Approval status | Approved · Rx/OTC |
| Primary target(s) | CA1 |
| Mechanism of action | Muscle relaxant |
| Indication | muscle relaxant |
| Disease area | neurology/psychiatry |
All known targets
Mechanisms of action (all sources)
- CA1 INHIBITOR
- Carbonic anhydrase I inhibitor
- CYP21A2 INHIBITOR
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- ACHE
- MAPK1
- NR1I2
- NPY2R
- NPY1R
- MMP9
- MMP1
- MLNR
- MC5R
- MC4R
- MC3R
- MAPK3
- MAPK14
- MAOA
- OPRD1
- LCK
- KCNH2
- HTR6
- HTR3A
- HTR2C
- HTR2B
- HTR2A
- HTR1A
- HRH2
- HRH1
- HMGCR
- NR3C1
- OPRK1
- ADORA1
- SLC29A1
- TBXAS1
- TBXA2R
- TARDBP
- TACR2
- TACR1
- SMN1
- SLCO1B3
- SLCO1B1
- SLC6A4
- SLC6A3
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
Drug classes
- Central Nervous System Agents
- Muscle Relaxants, Central
- Neuromuscular Agents
- Peripheral Nervous System Agents
- Muscle Relaxant
ATC classes
- M03B · MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS
Cross-references
Synonyms
- ATMEKSI
- Atmeksi
- DELAXIN
- FORBAXIN
- METHOCARBAMOL AND ASPIRIN
- ROBAXIN
- ROBAXIN-750
- ROBAXISAL
- Robaxin
- Tanlor
- glycerylguaiacolate carbamate
- guaiacol glyceryl ether carbamate
- guaiphenesin carbamate
- guaiamar carbamate
- Metocarbamol
- NSC-170960
- Delaxin
- Forbaxin
- Methocarbamol component of robaxisal
- Miolaxin
- Neuraxin
- Robaxin-750
- Metocarbamolo
- Lumirelax
- Parabaxin
- Relestrid
- Myolaxene
- Miolaxene
- Metofenia
- Miorilas
- Surquetil
- Reflexyn
- Methocal
- Tresortil
- Romethocarb
- Etroflex
- Miowas
Reported adverse events
- Bradycardia
- Anaphylactic reaction
- Amnesia
- Dyspepsia
- Hypersensitivity
- Leukopenia
- Urticaria
Look up METHOCARBAMOL in the interactive SynDRA portal →